Home000538 • SHE
add
Yunnan Baiyao Group Co Ltd
Previous close
¥55.57
Day range
¥55.50 - ¥56.96
Year range
¥53.56 - ¥60.69
Market cap
97.88B CNY
Avg Volume
7.07M
P/E ratio
19.48
Dividend yield
4.59%
Primary exchange
SHE
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 10.53B | 4.10% |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | 0.18 | 28.57% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | 2.48 | — |
Return on assets | — | — |
Return on capital | 2.69% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | 143.72M | -35.80% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".
As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
Founded
1902
Website
Employees
9,277
